Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

For more information on Age-Related Macular Degeneration go to the NHS website. If you've had a diagnosis, in addition to ...

最近，来自意大利技术研究院和圣马蒂诺医院的研究人员发现了一种名为Ziapin2的分子，它像一个精确的“光开关”，可以在视网膜中恢复对光的正常反应。这项研究发表在2025年1月11日的Nature Communications期刊上，论文标题为“A ...

Collaboration between TLI and AMDF underscores a shared commitment to making a meaningful difference in the lives of those affected by AMD. Together, TLI and AMDF are dedicated to advancing awareness, ...

In response to the TGA's approval of a new drug to treat macular degeneration, UNSW researcher Dr Lisa Nivison-Smith provides context about the ...

Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

OT asked the experts what delegates can expect to hear in clinical imaging, from skills development to applications of the ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced upcoming ...